title: Edoxaban and the need for outcomes-based NOAC dosing.
authors.affiliation: Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27705, USA. Electronic address: manesh.patel@duke.edu.
authors.forename: Manesh R
authors.initials: MR
authors.lastname: Patel
authors.affiliation: Duke Heart Center, Duke University Medical Center, Durham, NC 27705, USA.
authors.forename: Jeffrey B
authors.initials: JB
authors.lastname: Washam
mesh_terms: D001281:Atrial Fibrillation / Q000188:drug therapy*; D065427:Factor Xa Inhibitors / Q000008:administration & dosage*; D006801:Humans; D011725:Pyridines / Q000008:administration & dosage*; D013844:Thiazoles / Q000008:administration & dosage*
chemical_list: D065427:Factor Xa Inhibitors; D011725:Pyridines; D013844:Thiazoles